These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 38295969

  • 1. Ultrasound and magnetic resonance imaging-based investigation of the role of perfusion and oxygen availability in menstrual pain.
    Cockrum RH, Tu FF, Kierzkowska O, Leloudas N, Pottumarthi PV, Hellman KM.
    Am J Obstet Gynecol; 2024 May; 230(5):553.e1-553.e14. PubMed ID: 38295969
    [Abstract] [Full Text] [Related]

  • 2. Abdominal skeletal muscle activity precedes spontaneous menstrual cramping pain in primary dysmenorrhea.
    Oladosu FA, Tu FF, Farhan S, Garrison EF, Steiner ND, Roth GE, Hellman KM.
    Am J Obstet Gynecol; 2018 Jul; 219(1):91.e1-91.e7. PubMed ID: 29733841
    [Abstract] [Full Text] [Related]

  • 3. Cine MRI during spontaneous cramps in women with menstrual pain.
    Hellman KM, Kuhn CS, Tu FF, Dillane KE, Shlobin NA, Senapati S, Zhou X, Li W, Prasad PV.
    Am J Obstet Gynecol; 2018 May; 218(5):506.e1-506.e8. PubMed ID: 29409786
    [Abstract] [Full Text] [Related]

  • 4. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S, Robbins J, West CR, Nemeth MA.
    Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
    [Abstract] [Full Text] [Related]

  • 5. The effect of nimesulide and naproxen on the uterine and ovarian arterial blood flow velocity. A Doppler study.
    Pirhonen J, Pulkkinen M.
    Acta Obstet Gynecol Scand; 1995 Aug; 74(7):549-53. PubMed ID: 7618455
    [Abstract] [Full Text] [Related]

  • 6. Valdecoxib for treatment of primary dysmenorrhea. A randomized, double-blind comparison with placebo and naproxen.
    Daniels SE, Torri S, Desjardins PJ.
    J Gen Intern Med; 2005 Jan; 20(1):62-7. PubMed ID: 15693930
    [Abstract] [Full Text] [Related]

  • 7. Laparoscopic Uterine Artery Occlusion Combined with Uterine-sparing Pelvic Plexus Block and Partial Adenomyomectomy for Adenomyosis: A Video Case Report.
    Chen D, Ai G, Yang W, Liu J, Luo N, Guo J, Cheng Z.
    J Minim Invasive Gynecol; 2021 Oct; 28(10):1681-1684. PubMed ID: 34051355
    [Abstract] [Full Text] [Related]

  • 8. Transvaginal sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis: association with symptoms.
    Pinzauti S, Lazzeri L, Tosti C, Centini G, Orlandini C, Luisi S, Zupi E, Exacoustos C, Petraglia F.
    Ultrasound Obstet Gynecol; 2015 Dec; 46(6):730-6. PubMed ID: 25728241
    [Abstract] [Full Text] [Related]

  • 9. Effects of naproxen sodium on menstrual prostaglandins and primary dysmenorrhea.
    Chan WY, Fuchs F, Powell AM.
    Obstet Gynecol; 1983 Mar; 61(3):285-91. PubMed ID: 6571974
    [Abstract] [Full Text] [Related]

  • 10. Low Serum Naproxen Concentrations Are Associated with Minimal Pain Relief: A Preliminary Study in Women with Dysmenorrhea.
    Oladosu FA, Tu FF, Garrison EF, Dillane KE, Roth GE, Hellman KM.
    Pain Med; 2020 Nov 01; 21(11):3102-3108. PubMed ID: 32488234
    [Abstract] [Full Text] [Related]

  • 11. Three-dimensional power Doppler assessment of uterine vascularization in women with primary dysmenorrhea.
    Royo P, Alcázar JL.
    J Ultrasound Med; 2008 Jul 01; 27(7):1003-10. PubMed ID: 18577663
    [Abstract] [Full Text] [Related]

  • 12. Cyclic changes in T2* relaxometry of human uterus during the menstrual cycle using BOLD MR imaging.
    Li Y, Lai M, Li Q, Fu C, Zhang Q.
    Eur J Radiol; 2022 Nov 01; 156():110563. PubMed ID: 36272225
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the efficacy of Fructus agni casti in women with severe primary dysmenorrhea: a prospective comparative Doppler study.
    Aksoy AN, Gözükara I, Kabil Kucur S.
    J Obstet Gynaecol Res; 2014 Mar 01; 40(3):779-84. PubMed ID: 24245554
    [Abstract] [Full Text] [Related]

  • 14. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
    Shaw ST, Macaulay LK, Sun NC, Tanaka MS, Roche PC.
    Contraception; 1983 Feb 01; 27(2):131-40. PubMed ID: 6682747
    [Abstract] [Full Text] [Related]

  • 15. Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhoea and menorrhagia.
    Rees MC, DiMarzo V, Tippins JR, Morris HR, Turnbull AC.
    J Endocrinol; 1987 May 01; 113(2):291-5. PubMed ID: 3035052
    [Abstract] [Full Text] [Related]

  • 16. Zinc treatment prevents dysmenorrhea.
    Eby GA.
    Med Hypotheses; 2007 May 01; 69(2):297-301. PubMed ID: 17289285
    [Abstract] [Full Text] [Related]

  • 17. Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine-device use.
    Christelle K, Norhayati MN, Jaafar SH.
    Cochrane Database Syst Rev; 2022 Aug 26; 8(8):CD006034. PubMed ID: 36017945
    [Abstract] [Full Text] [Related]

  • 18. Endometrial vascular development in heavy menstrual bleeding: altered spatio-temporal expression of endothelial cell markers and extracellular matrix components.
    Biswas Shivhare S, Bulmer JN, Innes BA, Hapangama DK, Lash GE.
    Hum Reprod; 2018 Mar 01; 33(3):399-410. PubMed ID: 29309596
    [Abstract] [Full Text] [Related]

  • 19. Naproxen, paracetamol and pamabrom versus paracetamol, pyrilamine and pamabrom in primary dysmenorrhea: a randomized, double-blind clinical trial.
    Ortiz MI, Murguía-Cánovas G, Vargas-López LC, Silva R, González-de la Parra M.
    Medwave; 2016 Oct 24; 16(9):e6587. PubMed ID: 27813503
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.